Try Alerts Free   |   Login
Health Care › Services-Commercial Physical & Biological Research

MXCT Price Correlated With Financials For MaxCyte

Free historical financial statements for MaxCyte Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 4 quarters since 2021. Compare with MXCT stock chart to see long term trends.

MXCT Stock Compared to Quarterly

MXCT Income Statement

Revenue, Net:11587300
Revenue Per Share:0.1141
Cost of Goods & Services Sold:1062600
Gross Profit:10524700
Selling, General & Admin Expense:6632500
Research & Development Expense:3765300
Total Operating Expenses:14683800
Operating Income:-4159100
Net Income:-4067300
Earnings Per Share, Basic:-0.04
Shares Outstanding, Basic Avg:101540052

MXCT Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:487400
Change in Accounts Receiveable:1750800
Net Cash from Operations:-3694200
Net Cash from Operations Per Share:-0.0364
Net Cash from Financing Activities:892600
Property, Plant & Equipment Purchases:5999500
Net Cash from Investing Activities:194796500
Net Change in Cash & Equivalents:191994900

MXCT Balance Sheet

Cash and Cash Equivalents:239777300
Short-Term Investments:6498600
Accounts Receivable, Net:8627800
Total Current Assets:265794700
Property, Plant & Equipment, Net:13203700
Total Assets:290955200
Accounts Payable:4365700
Total Short-Term Liabilities:15548400
Total Liabilities:28770400

Data imported from MaxCyte Inc. SEC filings. Check original filings before making any investment decision.